Operating Metrics 營運指標
Novo Nordisk A/S (NVO) Operating Metrics 營運指標
Novo Nordisk A/S NVO 最近 8 季公司營運 KPI、指標定義、跨期趨勢與官方來源。
資料截至：2026-06-30
最新營運指標
- Adjusted GLP-1 Diabetes Sales
- 36,784 DKK M · 2026-06-30 來源：Novo Nordisk
- Adjusted Obesity Care Sales
- 23,152 DKK M · 2026-06-30 來源：Novo Nordisk
- Adjusted Wegovy Injectable Sales
- 19,484 DKK M · 2026-06-30 來源：Novo Nordisk
- Reported GLP-1 Diabetes Sales (Legacy)
- 37,527 DKK M · 2025-12-31 來源：Novo Nordisk
- Reported Obesity Care Sales (Legacy)
- 22,445 DKK M · 2025-12-31 來源：Novo Nordisk
- Reported Wegovy Sales (Legacy)
- 21,864 DKK M · 2025-12-31 來源：Novo Nordisk
- Full-Time Equivalent Employees (Legacy)
- 68,794 employees · 2025-12-31 來源：Novo Nordisk
季度趨勢
| 指標 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q4 FY2024 | Q3 FY2024 |
|---|---|---|---|---|---|---|---|---|
| Adjusted GLP-1 Diabetes Sales | 36,784 DKK M | 32,731 DKK M | — | — | — | — | — | — |
| Adjusted Obesity Care Sales | 23,152 DKK M | 20,912 DKK M | — | — | — | — | — | — |
| Adjusted Wegovy Injectable Sales | 19,484 DKK M | 18,235 DKK M | — | — | — | — | — | — |
| Reported GLP-1 Diabetes Sales (Legacy) | — | — | 37,527 DKK M | 36,735 DKK M | 38,366 DKK M | 39,574 DKK M | 42,173 DKK M | 34,935 DKK M |
| Reported Obesity Care Sales (Legacy) | — | — | 22,445 DKK M | 21,106 DKK M | 20,372 DKK M | 18,424 DKK M | 21,406 DKK M | 18,801 DKK M |
| Reported Wegovy Sales (Legacy) | — | — | 21,864 DKK M | 20,354 DKK M | 19,528 DKK M | 17,360 DKK M | 19,866 DKK M | 17,304 DKK M |
| Full-Time Equivalent Employees (Legacy) | — | — | 68,794 employees | 68,794 employees | 78,387 employees | 77,406 employees | 76,302 employees | 71,880 employees |
資料來源
- Financial Workbook Q2 2026 · Novo Nordisk · 2026-08-04
- Financial Workbook Q1 2026 · Novo Nordisk · 2026-05-06
- Full-Year 2025 Financial Workbook · Novo Nordisk · 2026-02-04